Screener
Celldex Therapeutics CLDX Business Segments — Product Development Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept cldx:ProductDevelopmentExpense.
The source filing: Celldex Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091984
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Personnel | $15,885 | $14,129 | $31,454 | $27,729 |
| Laboratory supplies | 2,593 | 1,544 | 4,051 | 3,712 |
| Facility | 1,178 | 1,398 | 2,118 | 2,803 |
| Product development (b) | 41,746 | 33,536 | 91,903 | 65,702 |
| Other expenses (c) | 6,140 | 3,589 | 11,017 | 6,864 |
| Total R&D expense | $67,542 | $54,196 | $140,543 | $106,810 |
Item 1. Unaudited Financial Statements
FAQ
- What is Celldex Therapeutics's business segments — product development expense?
- Celldex Therapeutics (CLDX) reported business segments — product development expense of $41.75M in Q2 2026.
- How has Celldex Therapeutics's business segments — product development expense changed year-over-year?
- Celldex Therapeutics's business segments — product development expense increased by 24.5% year-over-year, from $33.54M to $41.75M.
- What does business segments — product development expense mean?
- This metric measures the specific costs directly attributable to the clinical development and advancement of the company's therapeutic candidates. It focuses on the capital allocated to moving pipeline products through various phases of clinical trials and regulatory approval processes. This is a key indicator of the company's progress toward commercializing its drug portfolio.
Ask your AI about Celldex Therapeutics's business segments — product development expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude